Haematopoiesis, the process of mature blood and immune cell production, is functionally organized as a hierarchy, with selfrenewing haematopoietic stem cells and multipotent progenitor cells sitting at the very top 1,2 . Multiple models have been proposed as to what the earliest lineage choices are in these primitive haematopoietic compartments, the cellular intermediates, and the resulting lineage trees that emerge from them 3-10 . Given that the bulk of studies addressing lineage outcomes have been performed in the context of haematopoietic transplantation, current models of lineage branching are more likely to represent roadmaps of lineage potential than native fate. Here we use transposon tagging to clonally trace the fates of progenitors and stem cells in unperturbed haematopoiesis. Our results describe a distinct clonal roadmap in which the megakaryocyte lineage arises largely independently of other haematopoietic fates. Our data, combined with single-cell RNA sequencing, identify a functional hierarchy of unilineage-and oligolineage-producing clones within the multipotent progenitor population. Finally, our results demonstrate that traditionally defined long-term haematopoietic stem cells are a significant source of megakaryocyte-restricted progenitors, suggesting that the megakaryocyte lineage is the predominant native fate of longterm haematopoietic stem cells. Our study provides evidence for a substantially revised roadmap for unperturbed haematopoiesis, and highlights unique properties of multipotent progenitors and haematopoietic stem cells in situ.
Haematopoiesis, the process of mature blood and immune cell production, is functionally organized as a hierarchy, with selfrenewing haematopoietic stem cells and multipotent progenitor cells sitting at the very top 1,2 . Multiple models have been proposed as to what the earliest lineage choices are in these primitive haematopoietic compartments, the cellular intermediates, and the resulting lineage trees that emerge from them [3] [4] [5] [6] [7] [8] [9] [10] . Given that the bulk of studies addressing lineage outcomes have been performed in the context of haematopoietic transplantation, current models of lineage branching are more likely to represent roadmaps of lineage potential than native fate. Here we use transposon tagging to clonally trace the fates of progenitors and stem cells in unperturbed haematopoiesis. Our results describe a distinct clonal roadmap in which the megakaryocyte lineage arises largely independently of other haematopoietic fates. Our data, combined with single-cell RNA sequencing, identify a functional hierarchy of unilineage-and oligolineage-producing clones within the multipotent progenitor population. Finally, our results demonstrate that traditionally defined long-term haematopoietic stem cells are a significant source of megakaryocyte-restricted progenitors, suggesting that the megakaryocyte lineage is the predominant native fate of longterm haematopoietic stem cells. Our study provides evidence for a substantially revised roadmap for unperturbed haematopoiesis, and highlights unique properties of multipotent progenitors and haematopoietic stem cells in situ.
To probe native lineage relationships in the fully unperturbed bone marrow, we used the Sleeping Beauty lineage-tracing model and TARIS (T7-amplification mediated recovery of integration sites), an improved transposon integration sequencing technique ( Fig. 1a and Extended Data Figs 1 and 2) 11 . Our analysis relies on comparing tags across multiple differentiated populations at different time points to understand the dynamics of lineage coupling, without the need to isolate and transplant prospective progenitor subsets (Fig. 1b ). We pulsed adult Sleeping Beauty mice with doxycycline (Dox) for two days and, at one, two, four, and eight weeks after induction, sorted transposon-labelled (DsRed + ) nucleated erythroblasts, megakaryocyte progenitors (MkP), granulocytes, monocytes, and B-cell progenitors (Fig. 1c) . Notably, control experiments demonstrated that negligible amounts of transposition occur one day after removal of Dox (Extended Data Fig. 3 ).
We observed that blood lineages were mostly segregated for the first two weeks, suggesting their replacement by unilineage progenitors during this period (Fig. 1d ). Later, we began to detect a significant number of shared tags across lineages, revealing the activity of oligolineage progenitors ( Fig. 1d and Extended Data Fig. 4 ). At four weeks, 40.5% (± 8.4%) of all monocyte-detected tags (approximately 289 ± 89 clones) were also found in the granulocyte compartment, confirming their well-established common origin (Fig. 1e) 4 . Unexpectedly, a similar proportion of erythroblast clones were also found shared with granulocyte/monocyte (myeloid) tags ( Fig. 1d, e ), revealing a common progenitor for erythrocytes, granulocytes, and monocytes at this stage. Remarkably, we detected virtually no MkP clones that were shared exclusively with erythroblasts during the whole period of observation, which would have been predicted had a megakaryocyte-erythroid progenitor (MEP)-like cell existed (Fig. 1d , e and Extended Data Fig. 4b ) 12, 13 . At eight weeks, our analysis revealed the activity of a set of multilineage clones (239 ± 58), with lymphoid (B-cell progenitor), granulocyte/monocyte, and erythroid contribution, but still with no presence in MkP, indicating the existence of megakaryocyte-deficient lympho-erythromyeloid progenitors (Fig. 1d, e ). We did observe a very small (9.7 ± 2.8), yet increasing, number of MkP tags shared with multiple lineages after eight weeks ( Fig. 1e and Extended Data Fig. 4a, b ), suggesting that clonal megakaryocyte-lineage production can also be associated with multilineage outcomes, although at lower frequencies. Spearman's rank correlation analyses of tag-read distribution between lineage pairs showed a progressive association of granulocyte/monocyte, erythro-myeloid, and lympho-myeloid progenitors, segregated from MkP ( Fig. 1f , g). To address potential sampling and sensitivity limitations, we performed independent TARIS amplifications (Extended Data Fig. 5 ) and clone-specific PCRs (not-shown). Taken together, our results provide evidence for novel lineage couplings during unperturbed haematopoiesis, in which the megakaryocyte lineage is produced largely independently from the other haematopoietic lineages, and argue for the robust activity of erythromyeloid and lympho-erythromyeloid progenitor clones.
We next aimed to identify ancestral relationships by comparing the clonal repertoires of differentiated cells and previously defined progenitor populations. Classically, oligopotent progenitors reside in the common myeloid progenitor (CMP), granulocyte-monocyte progenitor (GMP), and MEP phenotypic gates (referred together as myeloid progenitors, or MyPs) 4 . Our data revealed largely unilineage outcomes for detected MyPs (89.0 ± 0.8%), suggesting that these populations represent a collection of lineage-restricted progenitors, functionally validating predictions from single-cell expression profiling (Extended Data Fig. 6 ) [14] [15] [16] . We next focused on the multipotent progenitors (MPPs), the cellular subset proposed to be upstream of MyPs. At 1 and 2 weeks, we observed a small number of 'active' MPP tags (overlapping with Lin + tags), which aligned mostly with single lineages (1 week: 75.8 ± 5.0%; 2 weeks: 66.3 ± 6.1%), suggesting the existence of a small population of lineage-committed MPPs that rapidly produce differentiated progeny ( Fig. 2a, b and Extended Data Fig. 7a ). MPP output significantly increased at 4-8 weeks for all lineages (9.35 ± 0.6% of all MPP tags at 8 weeks), consisting mostly of oligolineage erythromyeloid clones (79.2 ± 5.3% of active MPP clones). A robust number of lympho-erythromyeloid MPP clones (12 ± 2) were detected beginning at eight weeks ( Fig. 2a ), consonant with our analysis of Lin + fractions ( Fig. 1f ). Although we also observed oligolineage
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MkP-producing MPP clones, MkP overlap was more lineage-restricted than any other lineage, even after eight weeks (MkP 67.8 ± 8.0% versus other 22.1 ± 4.6%; Fig. 2a , b and Extended Data Fig. 7b ), indicating that at least a subset of MPPs is responsible for a stable restricted contribution to the megakaryocyte lineage.
Our analyses also provided relative quantitative information about the dynamics of lineage replacement by MPPs. For instance, the average clone size of MPP-derived erythromyeloid clones at eight weeks was 18.3 ± 7.7-fold larger than non-MPP-derived clones, suggesting a significant cellular amplification, in contrast to the B-cell progenitor lineage (1.2 ± 0.4-fold; Fig. 2c ). In addition, we found that the erythroid lineage was replaced at the fastest rate, with at least 35% of all erythroblast reads overlapping with MPPs after just two weeks, from just a handful of erythroid-committed MPPs (Fig. 2d, e ). By comparison, the granulocyte/monocyte-producing MPPs achieved similar levels of replacement only after two months. Considering that our analysis cannot measure the contribution of MPP clones that disappear from the MPP pool (that is, by cell death or differentiation), our results probably underestimate the overall MPP contribution.
To provide further insight into the heterogeneity and hierarchy of the haematopoietic stem cell (HSC)/MPP compartment, we sorted subsets within these populations using previously described surface markers and interrogated their single-cell gene expression landscape using inDrop ( Fig. 3a-c) 9, 17 . Louvain-Jaccard clustering analysis of transcriptomes resulted in 12 reproducibly distinct clusters ( Fig. 3b ). Most analysed cells (78.9% of all subsets combined) fitted into one of three major clusters that we labelled as unprimed ('C1' , 'C2' , 'C3') on the basis of the lack of expression of lineage-restricted gene signatures (Supplementary Table 2 and Extended Data Figs 8 and 9). We also identified several primed clusters (21.1% of HSCs/MPPs) that formed branches defined by progressive expression of genes associated with line age commitment ( Fig. 3b-d, right) . Predictably, cells indexed as long-term (LT)-HSCs and MPP1s (also known as short-term (ST)-HSCs) mostly fitted into the 'C1' (67.9%) and 'C2' (78.3%) clusters, respectively. By contrast, other MPP subsets displayed different degrees of heterogeneity. MPP2s contained the largest proportion of primed cells (59.3%), and MPP4s the least (13.2%) ( Fig. 3c, d ). MPP2s comprised a larger number of erythroid-primed (18.7%) and megakaryocyteprimed (21.9%) cells, whereas MPP3s contained a larger number of granulocyte/monocyte-primed cells (20.8%) ( Fig. 3c, d and Extended Data Fig. 8b ). Using transposon tracing, we confirmed that MPP2s presented a preference for MkP production, and generated less multilineage output (5 ± 5% of all active clones) within the first week, where their immediate progeny is likely to be measured, compared with MPP3s and MPP4s (40.17 ± 11.4%) ( Fig. 3e , f). Analysis of tags not arising from upstream progenitors at four weeks revealed similar findings ( Fig. 3g, h) . On the contrary, MPP4s produced most lympho-erythromyeloid and multilineage clones ( Fig. 3h ) and preferentially overlapped with MPP1/ ST-HSCs, suggesting that at least a fraction of MPP4s represent direct activated progeny of MPP1/ST-HSCs ( Fig. 3i ). Combined, our data support the notion that a functional hierarchy, consisting of progenitors at varying degrees of lineage priming, exists already within HSCs/MPPs. Letter reSeArCH Our single-cell RNA sequencing data also revealed that a subset of marker-defined LT-HSCs exhibited megakaryocyte-lineage priming (Fig. 3c, d and Extended Data Fig. 9 ). This is in line with previous reports of multipotent, yet platelet-biased, subsets of LT-HSCs in the context of transplantation 10, [18] [19] [20] [21] [22] [23] . However, the physiological relevance of this observation in native haematopoiesis is unknown. With these precedents, we analysed the Lin + transposon tag overlap of sorted LT-HSCs. Although only a very small number of LT-HSC clones was active four weeks after labelling (5.5 ± 2.3%), remarkably a large majority of these clones were found exclusively in the MkP population (Fig. 4a, b and Extended Data Fig. 10a ). This megakaryocyte-restricted output of LT-HSCs was more pronounced after 30 weeks post-labelling (MkP: 13.3 ± 5.6%; lymphoid/erythroid/myeloid: 3.2 ± 1.0%) ( Fig. 4c ). Quantitatively, LT-HSCs accounted for replacing at least 31% of the total MkP pool, compared with just 3.8% of granulocyte/monocyte and erythroblast reads ( Fig. 4d ). Among all MkP that had a detectable tag in primitive populations, approximately half demonstrated overlap with LT-HSCs and the other half with MPPs (where no LT-HSC tag was detected) (Extended Data Fig. 10b ). MPP-overlapping clones contributed to the megakaryocyte lineage to a similar extent as LT-HSCs, markedly differing from lympho-erythromyeloid output, which is predominantly MPP-driven ( Fig. 4e and Extended Data Fig. 10c ). Our analyses also revealed that many LT-HSCs contribute to MkP in the absence of any intermediates in the MPP compartment ( Fig. 4a ), suggesting that at least a subset of LT-HSCs generates megakaryocyte lineage cells through a 'direct' pathway.
Previous studies have shown that the commonly used LT-HSC gate contains unilineage CD41 + megakaryocyte-restricted progenitors as Letter reSeArCH assayed by transplant or culture 10, 22 . To rule out potential contamination by such cells, we aimed to determine whether megakaryocyteproducing LT-HSC clones in situ had properties of classic LT-HSCs in the context of transplantation. For this, we transplanted clonally labelled LT-HSCs isolated from mice four weeks after induction, and at 16 weeks post-transplantation we purified mature lineages from recipients and compared their transposon repertoires with those of cells initially isolated from the donor (Fig. 4f ). We observed that six out of eight detected megakaryocyte lineage-restricted LT-HSC clones in the donor were able to generate multilineage progeny in recipients (Fig. 4g, i) . We reached similar conclusions when evaluating the culture potential of in situ MkP-producing LT-HSC clones (Extended Data Fig. 10d, e ). Additionally, our results demonstrate that MkP production is not exclusive to the CD41 + LT-HSC fraction (Extended Data Fig. 10f, g) . Thus, we conclude that most megakaryocyte lineageproducing clones residing in the LT-HSC gate are not simply megakaryocyte-restricted progenitors, but clones that can exhibit multipotency upon transplantation.
Our work here uncovers critical features of the native haematopoietic process. In our model, as much as half of the megakaryocyte lineage is produced independently of other lineages by cells at the top of the haematopoietic ladder ( Fig. 4j) . A heterogeneous hierarchy of lineage-restricted and oligolineage progenitors, historically classified as MPPs, produce other haematopoietic lineages with selective lineage couplings. Although our work still supports a model for progressive restriction of developmental potential, it suggests that these events are clonally heterogeneous and occur much earlier in the haematopoietic hierarchy, in line with recent data 7, 8, 14, 16 . Although our data fail to provide any evidence for CMP or MEP fates in situ, many experiments have provided evidence for MEP-like cells at a clonal level 4, 12, 13, 24 . We posit that while megakaryocyte-erythrocyte bipotential exists in transplant or culture settings, this fate is not substantially manifested in unperturbed conditions. Alternatively, such cellular behaviour might be too transient to be captured with our technology.
Our data demonstrate that at least a fraction of LT-HSCs behave as a potent source of MkP, indicating that the megakaryocyte fate is the predominant fate of HSCs in situ. However, these same cells exhibit potential for multilineage outcomes following transplantation. Thus, our findings highlight the critical differences between studying native fate versus potential in stem cell biology. Although we are unable to conclude whether a particular subset or all LT-HSCs will eventually display megakaryocyte-producing behaviour, we favour the idea that most LT-HSC clones transition through a megakaryocyte-primed state with age. Our data also suggest that an MPP population (within MPP2) is involved in megakaryocyte production. It remains to be determined whether these represent two different pathways for megakaryocyte production or whether LT-HSCs are upstream of MPP2s. Finally, our results are still consonant with the idea that adult LT-HSCs have a limited lympho-erythromyeloid output during steady state 11, 25 , although this finding has been debated 26 . Future work with second-generation cell barcoding strategies 27, 28 in combination with Cre-based labelling will be needed to elucidate full lineage histories and determine the mechanisms of fate restriction.
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No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Mice. The M2/HSB/Tn mice were generated as previously described 11 . To induce transposon mobilization, 8-to 10-week-old male or female mice with the M2/ HSB/Tn genotype were fed with 2 mg ml −1 Dox together with 5 mg ml −1 sucrose in drinking water for 48 h. Thereafter, Dox was removed and successful labelling was verified by retro-orbital sinus peripheral blood collection and analysis (70 μ l) after 1 week. All animal procedures were approved by the Boston Children's Hospital Institutional Animal Care and Use Committee. Previous studies have estimated that most haematopoietic lineages are replaced by MPPs within 1-2 months after label 25, [29] [30] [31] . Thus, for Lin + lineage coupling studies, M2/HSB/Tn mice were analysed within the first 8 weeks after labelling. Since MyPs have limited selfrenewal capacity and are rapidly replaced by MPPs, we performed the MyP analysis at short time points after labelling (1 week) and only considered transposon tags not simultaneously present in MPPs. Bone marrow preparation. After euthanasia, whole bone marrow (excluding the cranium) was immediately isolated in 2% fetal bovine serum in phosphate buffered saline, and erythrocytes were removed with red blood cell lysis buffer. CD45.1 (Ly5.1) mice were used as transplantation recipients (B6.SJL-Ptprca Pep3b/BoyJ, stock 002014, the Jackson Laboratory). FACS. Lineage depletion was performed using magnetic-assisted cell sorting (Miltenyi Biotec) with anti-biotin magnetic beads and the following biotinconjugated lineage markers: CD3e, CD19, Gr1, Mac1, and Ter119. Cell populations from bone marrow were purified through four-way sorting using FACSAria (Becton Dickinson) and six-way sorting using MoFlo XDP (Beckman Coulter). The following combinations of cell surface markers were used to define these cell populations. Erythroblasts: 7/4 − Ly6G − Ter119 + CD71 + FSC hi ; granulocytes: Ly6G
Other populations are defined in Supplementary Table 1 . Representative examples of sorted populations are shown in Supplementary Figs 1-3 . Flow cytometry data were analysed with FlowJo (Tree Star). For transposon tag content extraction and analysis, we FACS-sorted all the available cells from the whole bone marrow extract using purity modes (approximately 98% purity) at about 75-80% efficiency. The antibodies (their clone number, the commercial house, and concentration) were as follows: Ly6B. Transplantation assays. Whole bone marrow cells or sort-purified LT-HSCs from M2/HSB/Tn mice were transplanted in 150 μ l of α MEM (Gibco, Thermo Fisher Scientific) through retro-orbital injection into γ -irradiated recipient mice (split dose of 2.5 + 2.5 Gy for sublethal irradiation, and 5.5 + 5.5 Gy for lethal irradiation, with a 2 h interval). Donor cell engraftment and label frequency were analysed after 16 weeks using LSRII equipment (Becton Dickinson). HSC culture assays. One thousand sort-purified LT-HSCs from M2/HSB/Tn mice were cultured together with 10,000 MS-5 stromal cells in round-bottom 96-well plates together with SCF (100 ng ml −1 ), TPO (100 ng ml −1 ), Flt3L (50 ng ml −1 ), IL7 (20 ng ml −1 ), IL3 (10 ng ml −1 ), IL11 (50 ng ml −1 ), and GM-CSF (20 ng ml −1 ) in α MEM with 1% penicillin/streptomycin and 10% FCS (Thermo Fisher) for 2 weeks, changing the medium 24 h after sort and then every 48 h (Becton Dickinson). Myeloid and lymphoid HSC progeny was FACS-sorted after labelling with Gr-1, Mac-1, CD19, and B220 antibodies (eBiosciences). All growth factors and cytokines were mouse recombinant and purchased from Peprotech. DNA isolation and amplification. Cells of interest were sorted into 1.7-ml tubes and concentrated into 5-10 μ l of buffer by low-speed centrifugation (700g for 5 min). Samples with fewer than 10,000 cells were subjected to whole-genome amplification with a Phi29 kit (Epicentre/Lucigen) according to the manufacturer's instructions. Samples with more than 10,000 cells were purified by a QIAamp DNA Micro kit (56304, Qiagen). TARIS. Our original technique for molecular identification of transposon integration sites was based on ligation-mediated (LM) PCRs. Others and we have observed significant tag amplification biases with this method, which limit the quantitative potential of the clonal data obtained 11, 32, 33 . To improve the current technique, we developed a method based on TARIS (Extended Data Fig. 1 ). This method provided similar sensitivity levels as LM-PCR but more quantitatively and reproducibly captures the clonal composition of complex samples (Extended Data Fig. 2) . For TARIS, the total purified DNA was subjected to enzymatic restriction with 10 U of HindIII-HF (NEB) overnight. TARIS adaptor primer was hybridized and extended using 1 U Klenow DNA polymerase (NEB) for 2 h. Then, total DNA was cleaned up using AMPure XP SPRI beads (Beckman Coulter) and used as a template for a 20 μ l T7 RNA polymerization reaction (NEB, High Yield Hiscribe T7 kit) overnight. Then, the template was digested with 1 U of Turbo DNase (Ambion) and the RNA product was polyadenylated using 1 U of polyA RNA polymerase (NEB). The polyA RNA was purified with SPRI beads, and then converted into cDNA using iScript reverse transcriptase (Biorad). TARIS cDNA was used as template for 30 PCR cycles using the HSB-transposon-specific Tn-1C, the MAF-Tn-1F, and the MAR-polyT primers for 30 cycles, and then 12 cycles of indexing PCR using the MP1 and ID primers (ID1-48) and the KAPA HiFi PCR kit. Solexa sequencing was performed on HiSeq 2000 (Illumina) at the Tufts Genomics Core. Tag identification and alignment was performed as previously described 11 . In brief, we extracted the transposon-containing reads from each fastq file, trimmed the adaptor and transposon sequences, and aligned the integration sites to the reference mouse genome (Ensembl mm9) using Bowtie 1.2. Then, reads were normalized between samples (per million reads). Sequences were always compared with at least one additional independently labelled mouse, with libraries prepared in parallel and sequenced in the same HiSeq lane to account for contaminations. Tags present in the control mouse samples were filtered out (contaminating reads). Next, read frequencies were column-normalized, and graphs were coloured using a logarithmic scale. For hierarchical clustering based on transposon tag distribution, we first determined the Spearman's correlation matrix for the compared populations and then performed agglomerative clustering (single method) using (1 − correlation coefficient) as the distance metric. Curve fitting was performed with the Lowess function. All indicated statistical tests were two-tailed parametric t-tests using Welch's s.d. correction (exceptions are mentioned where appropriate). Data visualization and statistical analysis was performed using Microsoft Excel, R (version 3.3.1), and GraphPad Prism (version 7). Primers used were TARIS adaptor primer (5′-GCATTAGCGGCCGCGAAATTAATACGACTCACTAT AGGGAGTCTAAAGCCATGACATC-3′ ), Tn1-C primer (5′ -CTTGTGTCATGC ACAAAGTAGATGTCC-3′ ), MAF-Tn1-1F primer (5′ -ACACTCTTTCCCT ACACGACGCTCTTCCGATCTNNNNCGAGTTTTAATGACTCCAACT-3′ ), and MAR-polyT primer (5′-GTGACTGGAGTTCAGACGTGTGCTCTTCCGA TCTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTV-3′ ). All primers were ordered from IDT DNA technologies, at 100 nmole scale and HPLC-purified. Single-cell RNA sequencing and low-level data processing. Transcriptome barcoding and preparation of libraries for single-cell mRNA sequencing was performed using the most up-to-date inDrops protocol 34 . For our experiment, the Lin-Sca1 + Kit + bone marrow fraction from a single BL6 mouse was labelled and FACS-sorted to purify the entire LT-HSC, MPP1, MPP2, MPP3, and MPP4 fractions. Approximately 2,000 cells of each fraction were encapsulated and libraries for all the populations were prepared the same day, with the same stock of primer-gels and RT-mix. Libraries were sequenced on an Illumina NextSeq 500 sequencer using a NextSeq High 75 cycle kit: 35 cycles for read 1, 6 cycles for index i7 read, and 51 cycles for read 2. Raw sequencing reads were processed using the inDrop pipeline previously described, with the following modifications: Bowtie version 1.1.1 was used with parameter -e 100; all ambiguously mapped reads were excluded from analysis; and reads were aligned to the Ensembl release 81 mouse mm10 cDNA reference. Data visualization using SPRING. We combined mRNA count matrices from five simultaneously processed and indexed libraries (LTHSC-2A, STHSC-2A, MPP4-2A, MPP3-2A, MPP2-2A). Cells with few mRNA counts (< 1,000 unique molecular identifiers) and stressed cells (mitochondrial gene-set Z-score > 1) were filtered out 35 . The remaining high-quality cells (4,248) were total-counts normalized. We next filtered genes, keeping those that were well detected (mean expression > 0.05) and highly variable (CV > 2). Finally, we reduced dimensionality by Z-scoring each gene and applying principal component analysis (PCA), retaining the top 50 principal components. The cells were then visualized using SPRING, a graph-based single-cell viewing interface 36 . Visual inspection of the SPRING plot revealed a strong cell-cycle signature defined by high expression of genes associated with the G2/M phase (Ccnb1, Plk1, Cdc20, Aurka, Cenpf, Cenpa, Ccnb2 , Birc5, Bub1, Bub1b, Ccna2, Cks2, E2f5, Cdkn2d) . Hypothesizing that this Letter reSeArCH cell-cycle signature could affect high-dimensional distances between cells in a way that obscures their segregation by lineage-specific genes, we attempted to remove it 37 . Specifically, we filtered from the analysis genes that were significantly correlated with the sum Z-score of G2/M genes (P < 10 −4 , Bonferroni corrected; 401 genes total, resulting in 28,205 remaining genes). PCA and clustering analysis were repeated using the reduced gene list. Clustering of single-cell profiles. We performed unsupervised clustering of the processed single-cell data with the Louvain-Jaccard method package from ref. 38 . To assess cluster stability and choose the value of k, we downsampled 85% of cells and applied the Louvain-Jaccard method using 50 principal components. We tested k values from 10 to 30 and for each k we compared 100 times the randomly downsampled clustering using the Jaccard-index measurement in the R package fpc (Flexible Procedures for Clustering). We considered a Jaccard-index minimum of 0.75 as sufficiently robust and selected values of k > 30, which resulted in the identification of 11-12 clusters 39 . Differential expression analysis was performed using the method package from ref. 38 (results are included in Supplementary Table 2 ). Data availability. The Gene Expression Omnibus accession number is GSE90742. Additional data files will be made available upon reasonable request from the corresponding author. SPRING plots (with and without removal of the G2/M cell-cycle signature) are available for inspection at the following links: https://kleintools.hms. harvard.edu/tools/springViewer.html?cgi-bin/client_datasets/ARF2017_combined_ nocycle and https://kleintools.hms.harvard.edu/tools/springViewer.html?cgi-bin/ client_datasets/ARF2017_combined. 
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Extended Data Figure 10 | Additional data on clonal origin of MkP. a, Three independent transposon tag libraries were prepared and sequenced for LT-HSC, MPP, and the five Lin + populations, from one mouse at four weeks. Each column represents the combined tags detected from three amplicon libraries prepared for each population, to facilitate visualization of the smallest clones. Tags are coloured by frequency in each lineage, and organized by rank. b, Origin of megakaryocytes. Alignment of all MkP clones that had detectable tags in HSC/MPPs from a mixed library combining three independent sequencing reactions. Tags are coloured by frequency in each lineage (except for MkP), and organized by rank. Arrows indicate tags verified by clone-specific PCR. c, Alignment of transposon tags from all Lin + populations, LT-HSCs, and MPPs collected from 30-week-chased mice. Tags are coloured by frequency in each lineage, and organized by rank. d, Experimental design for testing in vitro myeloid and lymphoid potential from sorted LT-HSCs. e, In vitro myeloid potential of LT-HSCs. Alignment of donor Lin + tags with transposon tags obtained from myeloid and lymphoid cells derived from donor LT-HSCs after two weeks in culture. f, Clonal output of CD41 hi and CD41 lo LT-HSCs at four weeks after labelling. g, Quantification of megakaryocyte lineage replacement by CD41 hi versus CD41 lo LT-HSCs (measured as the percentage of overlapping/total MkP reads) at four weeks after labelling. Values are mean ± s.e.m. of three independent mice. 
Data exclusions
Describe any data exclusions. Some data were excluded based on the quality of library sequences. Samples that presented sequencing results with poor quality (based on FastQC score), DNA libraries that presented mostly sequences without transposon (>70%) and samples with less than 10% of the predicted number of Tn tags were excluded.
Replication
Describe whether the experimental findings were reliably reproduced.
Experimental findings were reliably reproduced. We did find a large variability in some of our observations, and these are indicated where appropriate.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Weaned mice from a Tn/Tn x M2/M2 HSB/HSB cross were selected randomly and separated into male and female cages. These mice were labeled with doxycyclin and randomly chosen at different time points for BM isolation.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
No blinding was performed during data collection.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance. Describe the software used to analyze the data in this study.
Custom code required for Tn tag integration analysis has been previously published (Sun et al. Nature 2014) For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
N/A
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
All antibodies were purchased from Biolegend or BD Biosciences, and are well characterized and validated by providers. Antibodies used and their concentrations are described in methods (page 10) Cell lines were regularly tested for mycoplasma contamination.
d. If any of the cell lines used are listed in the database of commonly misidentified cell lines maintained by ICLAC, provide a scientific rationale for their use.
Cells were used mainly for the purpose of validation of the technique of Tn integration quantitation, and not for describing any physiological features.
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
Tn and HSB mice were generated as previously described (Sun et al. Nature 2014(. Tn/Tn homozygous mice (backcrossed into the C57BL/6J background) were crossed to M2/M2 HSB/HSB homozygous mice (mixed C57BL/6J x 129/SvJ background). To induce Tn mobilization, 8-10 weeks old male or female mice with the M2/HSB/Tn genotype were fed with 2mg/ml Dox together with 5mg/ml sucrose in drinking water for 48h. Thereafter, Dox was removed and successful labelling was verified by retroorbital sinus peripheral blood collection and analysis (70 ul) after 1 week. All animal procedures were approved by the Boston Children's Hospital Institutional Animal Care and Use Committee.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
N/A
